Air emissions control systems maker Biorem's Q3 revenue down 24%

Biorem

17/11/2025 13:08

Overview

Biorem Q3 revenue down 24% yr/yr to C$11.3 mln

EPS for Q3 falls to C$0.07 from C$0.14 last year

Company reports record order backlog of C$71 mln

Outlook

Biorem expects strong revenue and earnings growth over the next 12 months

Company reports record order backlog of C$71 mln as of September 30, 2025

Biorem anticipates continued growth in order bookings

Result Drivers

ORDER BACKLOG - Record order backlog of C$71 mln driven by strong order bookings and strategic product adjustments

REVENUE IMPACT - Revenue decline attributed to customer construction timelines and delivery schedules

OPERATING EXPENSES - Decrease in operating expenses due to lower sales and marketing costs

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
C$11.25 mln
Q3 EPS
C$0.06
Q3 Net Income
C$1.16 mln
Q3 Basic EPS
C$0.07
Q3 Gross Profit
C$3.17 mln
Q3 Operating Expenses
C$1.55 mln


Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the environmental services & equipment peer group is "buy"

Wall Street's median 12-month price target for Biorem Inc is C$3.50, about 38.6% above its November 14 closing price of C$2.15

The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nCNWpv237a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)